Floatz logo

Xiaoyao Pill

Fibrocystic Disease of Breast

First Affiliated Hospital Xi'an Jiaotong UniversityPhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Fibrocystic Disease of Breast cohort.

Asset / SponsorPhaseRating
TAMOXIFEN
Medical College and Hospital Kolkata
Phase 4BB
Xiaoru Sanjie Capsules
First Affiliated Hospital Xi'an Jiaotong University
Phase 4BB
Iodine
Symbollon Pharmaceuticals
Phase 3B
Danazol
FemmePharma Global Healthcare, Inc.
Phase 2B
Abemaciclib
Mayo Clinic
Phase 2CCC

Same molecule, other indications

Xiaoyao Pill is also rated in:

Depression in Parkinson's DiseaseDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →